Harry Stylli

This inventor holds 17 USPTO granted patents and 29 published patent applications, plus 1 CIPO patent and 14 EPO patents. Top assignees: Biora Therapeutics, Inc., Immunis.ai, Inc., Progenity, Inc.. Active years: 2019-2026.

USPTO Granted Patents = 17 (Patent Applications = 29)

% Patents Active = 94.1

CIPO Patents = 1 (Patent Applications = 18)

EPO Patents = 14 (Patent Applications = 33)

Average Co-Inventor Count = 4.6

ph-index = 2

Forward Citations = 9(Granted Patents)

Company Filing History:

7 out of 17

Biora Therapeutics, Inc.

Years Active: 2019-2026

Loading Chart...

17 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12582809 - TREATMENT OF A DISEASE OF THE GASTROINTESTINAL TRACT WITH A PDE4 INHIBITOR (2026-03-24),

2. 12529109 - Methods of detecting prostate cancer (2026-01-20),

3. 12181477 - Methods of detecting prostate cancer (2024-12-31),

4. 12171764 - Treatment of a disease of the gastrointestinal tract with a JAK or other kinase inhibitor (2024-12-24),

5. 12150775 - Treatment of a disease of the gastrointestinal tract with an immunosuppressant (2024-11-26),

6. 12037645 - Methods of detecting cancer (2024-07-16),

7. 11857669 - Treatment of a disease of the gastrointestinal tract with a JAK inhibitor and devices (2024-01-02),

8. 11597762 - Treatment of a disease of the gastrointestinal tract with an IL-12/IL-23 inhibitor released using an ingestible device (2023-03-07),

9. 11596670 - Treatment of a disease of the gastrointestinal tract with IL-10 or an IL-10 agonist (2023-03-07),

10. 11585814 - Methods of detecting prostate cancer (2023-02-21),

11. 11523772 - Treatment of a disease of the gastrointestinal tract with an immunosuppressant (2022-12-13),

12. 11426566 - Treatment of a disease of the gastrointestinal tract with a TLR modulator (2022-08-30),

13. 11134889 - Treatment of a disease of the gastrointestinal tract with a SMAD7 inhibitor (2021-10-05),

14. 11033490 - Treatment of a disease of the gastrointestinal tract with a JAK inhibitor and devices (2021-06-15),

15. 10980739 - Treatment of a disease of the gastrointestinal tract with a chemokine/chemokine receptor inhibitor (2021-04-20),

Title: Inventor Harry Stylli: Pioneering Innovations in La Jolla

Introduction: Harry Stylli is a renowned inventor based in La Jolla, California, known for his groundbreaking contributions to the field of biotechnology and medical devices.

Latest Patents: Harry Stylli holds several patents related to advanced medical imaging technologies, minimally invasive surgical instruments, and personalized healthcare devices.

Career Highlights: With a background in bioengineering, Harry Stylli has led research teams in developing cutting-edge solutions for early disease detection and precision medicine. His work has significantly impacted the healthcare industry.

Collaborations: Throughout his career, Harry Stylli has collaborated with leading universities, research institutions, and medical professionals to bring his inventions from concept to market, ensuring their practicality and effectiveness.

Conclusion: Harry Stylli's dedication to innovation and improving patient outcomes has solidified his reputation as a visionary inventor in La Jolla and beyond.